GSK and Orphan Diseases: Doing the Right Thing is Also Good Business – Gerson Lehrman Group

GSK and Orphan Diseases: Doing the Right Thing is Also Good Business
Gerson Lehrman Group
roll out "me too" blockbuster drugs targeting common problems like cardiovascular disease — or, at the more trivial end of the spectrum, acid reflux.

Source:GSK and Orphan Diseases: Doing the Right Thing is Also Good Business – Gerson Lehrman Group

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>